Institutional Ownership Poseida Therapeutics, Inc. (PSTX)
This table provides information about the institutional ownership of Poseida Therapeutics, Inc. (PSTX). We have compiled data on the 7 institutions that hold shares in the stock, with a total of 5.44 Million shares, which have been reported (via 13F filing form) to have a value of $51.7 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,905,160
shares
|
$46.6 Million
0.0% of portfolio
|
Q2 2024
Reduced 0.91%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
299,297
shares
|
$2.84 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.74%
|
|
Cigogne Management Sa
Luxembourg, N4 |
Feb 14, 2025 Q4 2024 |
120,000
shares
|
$1.14 Million
0.68% of portfolio
|
Q4 2024
New holding
|
|
Deka Bank Deutsche Girozentrale
|
Apr 30, 2025 Q1 2025 |
100,000
shares
|
$950,000
0.0% of portfolio
|
Q2 2023
Added 25.0%
|
|
Rothschild Investment Corp
|
Oct 16, 2023 Q3 2023 |
12,000
shares
|
$114,000
0.0% of portfolio
|
Q4 2020
Reduced 33.33%
|
|
Antonetti Capital Management LLC
|
Nov 09, 2023 Q3 2023 |
400
shares
|
$3,800
0.0% of portfolio
|
Q3 2023
Added 300.0%
|
|
Ifp Advisors, Inc
|
May 05, 2025 Q1 2025 |
0
shares
|
$0
0.0% of portfolio
|
Q1 2025
New holding
|